DxDiscovery
Reno
About DxDiscovery
DxDiscovery is a research and development company for biotechnology. The creation of moderate, microbial monoclonal antibody antibodies is the corporate objective. These antibodies may be created as preventatives or treatments for infectious diseases, or they may be used in quick POC diagnostics. Products in their diagnostics portfolio will help in circumstances when the existing treatment protocol is time-consuming or very likely to yield erroneous results.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.7M
- Funding stage: Seed
- Last round: Seed (Oct 2020)
- Website: dxdiscovery.com
- Phone: 480-280-9192
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Product Research
Social Profiles
Canonical: https://fsome.com/organization/dxdiscovery-159261 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.